Clinical Trial Update: Mirtazapine in Cancer-related Poly-symptomatology [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating mirtazapine for cancer-related poly-symptomatology has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• mirtazapine (mirtazapine)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Cancer, Neoplasms | Phase 3 | Status: TERMINATED